Skip to main content

Table 1 Patient demographics

From: Effect of the DGAT1 inhibitor pradigastat on triglyceride and apoB48 levels in patients with familial chylomicronemia syndrome

 

Patient #1

Patient #2

Patient #3

Patient #4

Patient #5

Patient #6

Mean +/−SD

Age (years)

66

35

53

38

63

54

51.5 +/− 12.7

Weight (kg)

36.5

77.7

74.2

57.7

47.0

63.1

59.4 +/− 15.8

Height (cm)

159

175

175

162

153

166

165.0 +/− 8.8

BMI (kg/m2)

14.4

25.4

24.2

22.0

20.0

22.9

21.5 +/− 3.9

Gender

Female

Male

Male

Female

Female

Female

-

  1. All individuals were of the Caucasian race.
Back to article page

Lipids in Health and Disease

ISSN: 1476-511X